Skip to main content
BMEA logo

BMEA · Biomea Fusion, Inc.

Track BMEA — free
$2.03 +0.12 (+6.28%) At close · Sep 4
Market Cap
$147.14M
Shares
72.48M

BMEA metrics

52 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.03
Market cap
$147.14M

Price action

19 metrics
Price change (1W)
+17.3%
Price change (30D)
+59.8%
Price change (3M)
+59.8%
Price change (6M)
+46.0%
Price change (YTD)
+63.7%
Price change (1Y)
+10.9%
Trailing year
Price change (5Y)
-85.1%
52-week high
$2.67
52-week low
$0.96
Change from 52-week high
-24.0%
Change from 52-week low
+112.1%
Annualized volatility
90.4%
Beta
1.5
RSI (14D)
81.1
Price vs SMA 50
+45.2%
Price vs SMA 200
+47.6%
Avg volume (3M)
1.16M
Relative volume
2.9
Average dollar volume
$1.71M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
72.48M

Valuation

12 metrics
P / E (TTM)
Trailing earnings
PEG ratio
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
P / book
12.1
reciprocal yield 8.2%
FCF yield
TTM · current market cap
Buyback yield
P / FCF
P / operating cash flow
Earnings yield
-22.1%

Historical valuation

8 metrics
P / E historical average (3Y)
P / E historical average (5Y)
EV / revenue historical average (3Y)
EV / revenue historical average (5Y)
EV / EBIT historical average (3Y)
EV / EBIT historical average (5Y)
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings
2026-05-05

Profitability

9 metrics
Gross margin
Operating margin
Trailing 12 months
Net margin
Gross profit (TTM)
Operating profit (TTM)
−$58.06M
Net income (TTM)
−$32.54M
Trailing 12 months
Diluted EPS (TTM)
$-0.16
FCF margin
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
$-2.20
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share
$0.43

Growth

11 metrics
Revenue growth YoY
+0.0%
Year over year
Net income growth YoY
Revenue (TTM)
Trailing 12 months
EPS growth YoY
Shares change YoY
+78.1%
Year over year · more shares
Revenue CAGR (3Y)
Revenue CAGR (5Y)
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
FCF CAGR (5Y)

Quality

14 metrics
Return on equity
-268.1%
Return on assets
-88.2%
Debt / equity
Current ratio
3.5
EBITDA (TTM)
Free cash flow (TTM)
Quick ratio
3.5
Interest coverage
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Cash & equivalents
$34.82M
Total assets
$36.87M
Total debt

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$47.19M
Capital expenditures (TTM)
$82,000
R&D (TTM)
$40.78M
SG&A (TTM)
Stock compensation (TTM)
$6.95M
R&D / revenue
Stock compensation / revenue

Ownership (13F)

3 metrics
13F filers
62
13F filer change QoQ
-3
Institutional ownership
36.1%

Short interest

3 metrics
Short interest
13.5%
Latest settlement · 20.9 days to cover
Days to cover
20.9d
Short-squeeze score
89 / 100

Insider activity

2 metrics
Net insider buying (90D)
Insider-sentiment score

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1840439 CUSIP 09077A106 13F (30d) 44 filings 44 filers Visit website Investor relations